title: Prostate cancer: PLK-1 inhibition improves abiraterone efficacy.
authors.forename: Clemens
authors.initials: C
authors.lastname: Thoma
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D018797:Cell Cycle Proteins / Q000037:antagonists & inhibitors*; D006801:Humans; D008297:Male; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors*; D011518:Proto-Oncogene Proteins / Q000037:antagonists & inhibitors*
chemical_list: D000726:Androgen Antagonists; D018797:Cell Cycle Proteins; D011518:Proto-Oncogene Proteins; D017346:Protein Serine-Threonine Kinases